James S Burns Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James S Burns.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James S Burns. James S Burns is President and CEO in CASI Pharmaceuticals, Inc. ($CASI) and Director in VERMILLION, INC. ($VRML) and Director in Symmetry Surgical Inc. ($SSRG).
Latest Insider Trading Transactions of James S Burns
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AWH, CASI, SSRG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | VRML | VERMILLION, INC. | Burns James S | Director | Option Exercise | X | 1.80 | 11,250 | 20,250 | 0 | |
| Jun 09 2020 | VRML | VERMILLION, INC. | Burns James S | Director | Buy | X | 1.80 | 11,250 | 20,250 | 473,461 | 462.2 K to 473.5 K (+2.43 %) |
| Mar 23 2020 | VRML | VERMILLION, INC. | Burns James S | Director | Option Exercise | A | 0.68 | 113,300 | 77,044 | 113,300 | |
| Mar 23 2020 | VRML | VERMILLION, INC. | Burns James S | Director | Grant | A | 0.00 | 65,156 | 0 | 462,211 | 397.1 K to 462.2 K (+16.41 %) |
| Mar 28 2019 | VRML | VERMILLION, INC. | Burns James S | Director | Option Exercise | A | 1.29 | 91,451 | 117,972 | 91,451 | |
| Mar 28 2019 | VRML | VERMILLION, INC. | Burns James S | Director | Buy | P | 0.00 | 34,848 | 0 | 397,055 | 362.2 K to 397.1 K (+9.62 %) |
| Apr 17 2018 | VRML | VERMILLION, INC. | Burns James S | Director | Grant | A | 0.00 | 73,600 | 0 | 362,207 | 288.6 K to 362.2 K (+25.50 %) |
| Mar 27 2017 | VRML | VERMILLION, INC. | Burns James S | Director | Grant | A | 0.00 | 22,685 | 0 | 288,607 | 265.9 K to 288.6 K (+8.53 %) |
| Feb 15 2017 | VRML | VERMILLION, INC. | Burns James S | Director | Option Exercise | P | 1.80 | 11,250 | 20,250 | 11,250 | |
| Feb 15 2017 | VRML | VERMILLION, INC. | Burns James S | Director | Buy | P | 1.40 | 15,000 | 21,000 | 265,922 | 250.9 K to 265.9 K (+5.98 %) |
| Jul 01 2016 | SSRG | Symmetry Surgical ... | Burns James S | Director | Sell | D | 13.10 | 56,909 | 745,508 | 0 | 56.9 K to 0 (-100.00 %) |
| Mar 21 2016 | VRML | VERMILLION, INC. | Burns James S | Director | Grant | A | 0.00 | 31,818 | 0 | 250,922 | 219.1 K to 250.9 K (+14.52 %) |
| Jan 04 2016 | SSRG | Symmetry Surgical ... | Burns James S | Director | Grant | A | 0.00 | 15,556 | 0 | 59,687 | 44.1 K to 59.7 K (+35.25 %) |
| Jul 15 2015 | VRML | VERMILLION, INC. | Burns James S | Director | Grant | A | 0.00 | 36,082 | 0 | 219,104 | 183 K to 219.1 K (+19.71 %) |
| Jan 17 2007 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 1.70 | 200,000 | 340,000 | 200,000 | |
| Jun 19 2006 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 1.56 | 200,000 | 312,000 | 200,000 | |
| Jun 14 2006 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.58 | 5,000 | 7,900 | 70,000 | 65 K to 70 K (+7.69 %) |
| Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.37 | 7,500 | 17,775 | 65,000 | 57.5 K to 65 K (+13.04 %) |
| Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.36 | 3,900 | 9,204 | 57,500 | 53.6 K to 57.5 K (+7.28 %) |
| Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.39 | 400 | 956 | 53,600 | 53.2 K to 53.6 K (+0.75 %) |
| Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.40 | 2,800 | 6,720 | 53,200 | 50.4 K to 53.2 K (+5.56 %) |
| Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.35 | 400 | 940 | 50,400 | 50 K to 50.4 K (+0.80 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.68 | 500 | 1,840 | 49,500 | 49 K to 49.5 K (+1.02 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.65 | 200 | 730 | 49,000 | 48.8 K to 49 K (+0.41 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.63 | 3,107 | 11,278 | 48,800 | 45.7 K to 48.8 K (+6.80 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.64 | 4,900 | 17,836 | 45,693 | 40.8 K to 45.7 K (+12.01 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.67 | 1,993 | 7,314 | 40,793 | 38.8 K to 40.8 K (+5.14 %) |
| Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.66 | 3,800 | 13,908 | 38,800 | 35 K to 38.8 K (+10.86 %) |
| Dec 22 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 3.02 | 100,000 | 302,000 | 100,000 | |
| Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.70 | 6,500 | 11,050 | 35,000 | 28.5 K to 35 K (+22.81 %) |
| Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.69 | 2,600 | 4,394 | 28,500 | 25.9 K to 28.5 K (+10.04 %) |
| Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.68 | 100 | 168 | 25,900 | 25.8 K to 25.9 K (+0.39 %) |
| Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.67 | 400 | 668 | 25,800 | 25.4 K to 25.8 K (+1.57 %) |
| Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.66 | 400 | 664 | 25,400 | 25 K to 25.4 K (+1.60 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.00 | 4,200 | 8,400 | 25,000 | 20.8 K to 25 K (+20.19 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.99 | 1,600 | 3,184 | 20,800 | 19.2 K to 20.8 K (+8.33 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.97 | 900 | 1,773 | 19,200 | 18.3 K to 19.2 K (+4.92 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.98 | 6,500 | 12,870 | 18,300 | 11.8 K to 18.3 K (+55.08 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.95 | 6,100 | 11,895 | 11,800 | 5.7 K to 11.8 K (+107.02 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.92 | 500 | 960 | 5,700 | 5.2 K to 5.7 K (+9.62 %) |
| Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.93 | 5,200 | 10,036 | 5,200 | 0 to 5.2 K |
| Jun 17 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 2.14 | 500,000 | 1,070,000 | 500,000 |
Page: 1